The Role of Aspirin in the Prevention of Thrombotic Complications of Thalidomide and Anthracycline-Based Chemotherapy for Multiple Myeloma-Reference-Cited by-同舟云学术

The Role of Aspirin in the Prevention of Thrombotic Complications of Thalidomide and Anthracycline-Based Chemotherapy for Multiple Myeloma

Published:2005-12 Issue:12 Volume:80 Page:1568-1574
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Baz Rachid,Li Liang,Kottke-Marchant Kandice,Srkalovic Gordan,McGowan Bridget,Yiannaki Erin,Karam Mary Ann,Faiman Beth,Jawde Rony Abou,Andresen Steven,Zeldis Jerome,Hussein Mohamad A.

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients;Hussein;Cancer,2002

2. Updated results from a randomized multicenter trial of DVd vs VAd in patients with newly diagnosed multiple myeloma [abstract];Rifkin;J Clin Oncol,2004

3. A phase II trial of doxil, vincristine and reduced schedule dexamethasone (DVd) for patients with relapsed or refractory multiple myeloma [abstract];Masci;Blood,2004

4. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy;Hideshima;Blood,2000

5. Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy;Zangari;Blood,2002

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Risk of Venous Thromboembolism and Ischemic Stroke Stratified by VTE Risk Following Multiple Myeloma: A Korean Population-Based Cohort Study;Journal of Clinical Medicine;2024-05-11

2. Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma;Cancers;2024-02-29

3. Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug–induced thromboembolism;Blood Advances;2024-02-02

4. Hematologists’ awareness of venous thromboembolism in multiple myeloma: a national survey in China;Annals of Medicine;2023-11-20

5. Risk of thromboembolic events associated with different multiple myeloma regimens in Taiwan: a nested case-control study;Journal of Thrombosis and Thrombolysis;2023-09-22